Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alberto Merino-Mansilla"'
Autor:
Concepcion Casado, Cristina Galvez, Maria Pernas, Laura Tarancon-Diez, Carmen Rodriguez, Víctor Sanchez-Merino, Mar Vera, Isabel Olivares, Rebeca De Pablo-Bernal, Alberto Merino-Mansilla, Jorge Del Romero, Ramon Lorenzo-Redondo, Ezequiel Ruiz-Mateos, María Salgado, Javier Martinez-Picado, Cecilio Lopez-Galindez
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Abstract Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control viral replication. However, natural virological suppression and absence of immune dysfunction are not always long-term sustained. We define e
Externí odkaz:
https://doaj.org/article/9afa80bdaabf490c8c3d29884df46882
Autor:
Carolina Beltran-Pavez, Carolina B Ferreira, Alberto Merino-Mansilla, Amanda Fabra-Garcia, Maria Casadella, Marc Noguera-Julian, Roger Paredes, Alex Olvera, Isabel Haro, Christian Brander, Felipe Garcia, Jose M Gatell, Eloisa Yuste, Victor Sanchez-Merino
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208345 (2018)
Preventive HIV-1 vaccine strategies rely on the elicitation of broadly neutralizing antibody (bNAb) responses, but their induction in vivo by vaccination remains challenging. Considering that the ability of an epitope to elicit effective humoral immu
Externí odkaz:
https://doaj.org/article/21101a16974d423b9db3e415e5522e6b
Autor:
Maria Pernas, Victor Sanchez-Merino, Concepcion Casado, Alberto Merino-Mansilla, Isabel Olivares, Eloisa Yuste, Cecilio Lopez-Galindez
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134054 (2015)
This study evaluated the neutralization breadth in dually infected (DI) HIV-1 long-term non-progressor elite controller patients (LTNP-EC) using a representative minipanel of 6 viruses from 5 different subtypes. Our results showed an improved neutral
Externí odkaz:
https://doaj.org/article/d1f80ba92c3d40068c0f79d5859df3a1
Autor:
Christian Brander, Alex Olvera, Carolina Beltran-Pavez, Ilja Bontjer, Eloisa Yuste, Nuria González, Victor Sanchez-Merino, José M. Miró, Alberto Merino-Mansilla, José Alcamí, Rogier W. Sanders, Maria Pernas
Publikováno v:
Journal of Virology
Repisalud
Instituto de Salud Carlos III (ISCIII)
Journal of virology, 96(1):e01343-21. American Society for Microbiology
Repisalud
Instituto de Salud Carlos III (ISCIII)
Journal of virology, 96(1):e01343-21. American Society for Microbiology
Longitudinal studies in HIV-1 infected individuals have indicated that 2-3 years of infection are required to develop broadly neutralizing antibodies. However, we have previously identified individuals with broadly neutralizing activity (bNA) in earl
Autor:
Cecilio López-Galíndez, Rebeca S. de Pablo-Bernal, Carmen Rodríguez, Isabel Olivares, Ezequiel Ruiz-Mateos, Maria Pernas, Mar Vera, Alberto Merino-Mansilla, Ramon Lorenzo-Redondo, Victor Sanchez-Merino, Maria Cristina O. Salgado, Cristina Gálvez, Concepción Casado, Javier Martinez-Picado, Laura Tarancon-Diez, Jorge del Romero
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control viral replication. However, natural virological suppression and absence of immune dysfunction are not always long-term sustained. We define exceptiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b214399cf8eb1e7b6c313351383dbee9
http://hdl.handle.net/10261/228602
http://hdl.handle.net/10261/228602
Autor:
Alberto Merino-Mansilla, Victor Sanchez-Merino, Anna Paús, Eloisa Yuste, Isabel Haro, María J. Gómara, José M. Gatell
Publikováno v:
Biochimica et Biophysica Acta (BBA) - General Subjects. 1860:1139-1148
Background: A slower progression of AIDS and increased survival in GBV-C positive individuals, compared with GBV-C negative individuals has been demonstrated; while the loss of GBV-C viremia was closely associated with a rise in mortality and increas
Autor:
Maria Casadellà, Carolina B. Ferreira, Marc Noguera-Julian, Alberto Merino-Mansilla, José M. Gatell, Roger Paredes, Alex Olvera, Isabel Haro, Victor Sanchez-Merino, Felipe García, Amanda Fabra-Garcia, Christian Brander, Eloisa Yuste, Carolina Beltran-Pavez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
PLoS One, 13
PLoS One, 13, 12
PLoS ONE, Vol 13, Iss 12, p e0208345 (2018)
PLOS ONE
instname
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
PLoS One, 13
PLoS One, 13, 12
PLoS ONE, Vol 13, Iss 12, p e0208345 (2018)
PLOS ONE
Preventive HIV-1 vaccine strategies rely on the elicitation of broadly neutralizing antibody (bNAb) responses, but their induction in vivo by vaccination remains challenging. Considering that the ability of an epitope to elicit effective humoral immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5bf0b32dd9857a13847182c92df3888
http://hdl.handle.net/10261/173897
http://hdl.handle.net/10261/173897
Autor:
Eloisa Yuste, Alberto Merino-Mansilla, Isabel Crespo, Laia Llinas, Victor Sanchez-Merino, Felipe García, José M. Gatell, Carolina B. Ferreira, Ignacio Pérez, Anuska Llano
Publikováno v:
Journal of Virology. 87:12227-12236
Little is known about the stability of HIV-1 cross-neutralizing responses. Taking into account the fact that neutralization breadth has been positively associated with plasma viral load, there is no explanation for the presence of broadly neutralizin
Autor:
John R. Mascola, Christian Manzardo, Juan Ambrosioni, Alberto Merino-Mansilla, Anke Schultz, Andreas Meyerhans, Gatell Jm, José Alcamí, Eloisa Yuste, Nuria González, David Nicolás, Miró Jm, Victor Sanchez-Merino, A. Fabra-Garcia
Publikováno v:
Journal of Virology
CIÊNCIAVITAE
Europe PubMed Central
CIÊNCIAVITAE
Europe PubMed Central
A fraction of HIV-1 patients are able to generate broadly neutralizing antibodies (bNAbs) after 2 to 4 years of infection. In rare occasions such antibodies are observed close to the first year of HIV-1 infection but never within the first 6 months.